Gardasil 00006-4109
Generic: Human Papillomavirus Quadrivalent (types 6, 11, 16, And 18) Vaccine, Recombinant
Product NDC
00006-4109- Manufacturer
- Merck Sharp & Dohme Llc
- Dosage Form
- Injection, Suspension
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- June 8, 2006
- Listing Expires
- December 31, 2026
- Application
- BLA125126
Active Ingredients
| Ingredient | Strength |
|---|---|
| Human Papillomavirus Type 11 L1 Capsid Protein Antigen | 40 ug/.5mL |
| Human Papillomavirus Type 16 L1 Capsid Protein Antigen | 40 ug/.5mL |
| Human Papillomavirus Type 18 L1 Capsid Protein Antigen | 20 ug/.5mL |
| Human Papillomavirus Type 6 L1 Capsid Protein Antigen | 20 ug/.5mL |
Drug Class
Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]
Packaging Options(2)
10 SYRINGE in 1 CARTON (0006-4109-02) / .5 mL in 1 SYRINGE (0006-4109-01)
6 SYRINGE in 1 CARTON (0006-4109-09) / .5 mL in 1 SYRINGE (0006-4109-01)
Related Products
All Human Papillomavirus Quadrivalent (types 6, 11, 16, And 18) Vaccine, Recombinant NDC codes →External Resources